1 The cardiovascular and sedative effects of FLA-136 have been compared with those of clonidine after intracerebroventricular (i.c.v.) administration in the rat. The effects of both drugs on pre-and postsynaptic a-adrenoceptors in the periphery have been investigated after intravenous (i.v.) administration in the pithed rat. 2 In the anaesthetized rat, i.c.v. FLA-136 and clonidine produced dose-related hypotension, FLA-136 having three to 30 times less activity than clonidine; both drugs caused concomitant bradycardia. In the conscious rat i.c.v. FLA-136 had less sedative potential than clonidine, in terms of overt sedation assessed visually. 7 FLA-136, unlike clonidine, did not stimulate peripheral pre-or postsynaptic a-adrenoceptors in the pithed rat. 8 FLA-136 is a novel centrally-acting hypotensive compound which, unlike clonidine, selectively stimulates central a-autoreceptors (yohimbine-sensitive) in the rat; these autoreceptors may be different from peripheral pre-and postsynaptic a-adrenoceptors. The results suggest that clonidine lowers blood pressure by stimulation of two types of central postsynaptic x-adrenoceptors in the rat; one type being sensitive to yohimbine and the other to prazosin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.